Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects (GCHT01)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by GeneCure Biotechnologies
Sponsor:
Information provided by (Responsible Party):
GeneCure Biotechnologies
ClinicalTrials.gov Identifier:
NCT01428596
First received: September 1, 2011
Last updated: March 12, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)